Toggle navigation
Publications
Researchers
Institutions
0
Sign In
Federated Authentication
(Click on the image)
Local Sign In
Password Recovery
Register
Sign In
David Scott Miller
AuthID:
R-00K-250
Publications
Confirmed
To Validate
Document Source:
All
Document Type:
All Document Types
Article (259)
Proceedings Paper (14)
Review (13)
Unpublished (12)
Book Chapter (7)
Letter (4)
Note (4)
Editorial Material (3)
Correction (1)
Year Start - End:
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
-
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
Order:
Year Dsc
Year Asc
Cit. WOS Dsc
IF WOS Dsc
Cit. Scopus Dsc
IF Scopus Dsc
Title Asc
Title Dsc
Results:
10
20
30
40
50
Confirmed Publications: 317
231
TITLE:
Ovarian preservation in stage I low-grade endometrial stromal sarcomas
AUTHORS:
Andrew J Li; Robert L Giuntoli; Richard Drake;
Sharon Young Byun
; Francisco Rojas; Denise Barbuto; Nancy Klipfel; Pamela Edmonds;
David Scott Miller
; Beth Y Karlan;
PUBLISHED:
2005
,
SOURCE:
Obstetrics and Gynecology,
VOLUME:
106,
ISSUE:
6
INDEXED IN:
Scopus
CrossRef
:
80
IN MY:
ORCID
|
CIÊNCIAVITAE
232
TITLE:
Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: A Gynecologic Oncology Group study
Full Text
AUTHORS:
Agustin A Garcia
; John A Blessing; Heinz Josef Lenz; Kathleen M Darcy; Robert S Mannel;
David Scott Miller
; Nader Husseinzadeh;
PUBLISHED:
2005
,
SOURCE:
Gynecologic Oncology,
VOLUME:
96,
ISSUE:
3
INDEXED IN:
Scopus
CrossRef
:
11
IN MY:
ORCID
|
CIÊNCIAVITAE
233
TITLE:
Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: A Gynecologic Oncology Group Study
Full Text
AUTHORS:
David Scott Miller
; John A Blessing; Steven Waggoner; Jeanne Schilder; Joel Sorosky; Jeffrey Bloss; Russell Schilder;
PUBLISHED:
2005
,
SOURCE:
Gynecologic Oncology,
VOLUME:
96,
ISSUE:
1
INDEXED IN:
Scopus
CrossRef
:
18
IN MY:
ORCID
|
CIÊNCIAVITAE
234
TITLE:
Phase II evaluation of topotecan in carcinosarcoma of the uterus: A Gynecologic Oncology Group study
Full Text
AUTHORS:
David Scott Miller
; John A Blessing; Jeanne Schilder; Adnan Munkarah; Yi Chun Lee;
PUBLISHED:
2005
,
SOURCE:
Gynecologic Oncology,
VOLUME:
98,
ISSUE:
2
INDEXED IN:
Scopus
CrossRef
:
44
IN MY:
ORCID
|
CIÊNCIAVITAE
235
TITLE:
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A Gynecologic Oncology Group study
AUTHORS:
Harry J Long; Brian N Bundy;
Edward C Grendys
; Jo Ann Benda; Scott S McMeekin; Joel Sorosky;
David Scott Miller
; Lynne A Eaton;
James V Fiorica
; Denise Mackey;
PUBLISHED:
2005
,
SOURCE:
Journal of Clinical Oncology,
VOLUME:
23,
ISSUE:
21
INDEXED IN:
Scopus
CrossRef
:
434
IN MY:
ORCID
|
CIÊNCIAVITAE
236
TITLE:
Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis
Full Text
AUTHORS:
Jayanthi S Lea; Robert Coleman; Aleena Kurien; John O Schorge;
David Scott Miller
; John D Minna; Carolyn Y Muller;
PUBLISHED:
2004
,
SOURCE:
American Journal of Obstetrics and Gynecology,
VOLUME:
190,
ISSUE:
3
INDEXED IN:
Scopus
CrossRef
:
35
IN MY:
ORCID
|
CIÊNCIAVITAE
237
TITLE:
Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
Full Text
AUTHORS:
Franco M Muggia; John A Blessing;
Michael Method
;
David Scott Miller
; Gary A Johnson;
Roger B Lee
; Andrew Menzin;
PUBLISHED:
2004
,
SOURCE:
Gynecologic Oncology,
VOLUME:
92,
ISSUE:
2
INDEXED IN:
Scopus
CrossRef
:
44
IN MY:
ORCID
|
CIÊNCIAVITAE
238
TITLE:
Oral dexamethasone attenuates Doxil®-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies
Full Text
AUTHORS:
Richard D Drake; Michael M Lin; Melanie King; Diana Farrar;
David Scott Miller
; Robert L Coleman;
PUBLISHED:
2004
,
SOURCE:
Gynecologic Oncology,
VOLUME:
94,
ISSUE:
2
INDEXED IN:
Scopus
CrossRef
:
44
IN MY:
ORCID
|
CIÊNCIAVITAE
239
TITLE:
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer
AUTHORS:
John O Schorge; Richard D Drake; Hang Lee; Steven J Skates; Ramababu Rajanbabu;
David Scott Miller
; Jae Hoon Kim; Daniel W Cramer; Ross S Berkowitz; Samuel C Mok;
PUBLISHED:
2004
,
SOURCE:
Clinical Cancer Research,
VOLUME:
10,
ISSUE:
10
INDEXED IN:
Scopus
CrossRef
:
64
IN MY:
ORCID
|
CIÊNCIAVITAE
240
TITLE:
Other primary malignancies in patients with uterine corpus malignancy
Full Text
AUTHORS:
Jacquelyn B Delin;
David Scott Miller
; Robert L Coleman;
PUBLISHED:
2004
,
SOURCE:
American Journal of Obstetrics and Gynecology,
VOLUME:
190,
ISSUE:
5
INDEXED IN:
Scopus
CrossRef
:
3
IN MY:
ORCID
|
CIÊNCIAVITAE
Add to Marked List
Check All
Export
×
Publication Export Settings
BibTex
EndNote
APA
CSV
PDF
Export Preview
Print
×
Publication Print Settings
HTML
PDF
Print Preview
Page 24 of 32. Total results: 317.
<<
<
20
21
22
23
24
25
26
27
28
>
>>
×
Select Source
This publication has:
2 records from
ISI
2 records from
SCOPUS
2 records from
DBLP
2 records from
Unpaywall
2 records from
Openlibrary
2 records from
Handle
2 records from
DataCite
Please select which records must be used by Authenticus!
×
Preview Publications
© 2025 CRACS & Inesc TEC - All Rights Reserved
Privacy Policy
|
Terms of Service